Roll up the Sleeves! When the bell rang at previous close Neurocrine Biosciences, Inc. (NBIX) was up 1.47%

At the end of the latest market close, Neurocrine Biosciences, Inc. (NBIX) was valued at $128.47. In that particular session, Stock kicked-off at the price of $128.94 while reaching the peak value of $130.99 and lowest value recorded on the day was $127.53. The stock current value is $130.36.

Neurocrine Biosciences, Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $131.00 on 06/23/20, with the lowest value was $72.14 for the same time period, recorded on 03/18/20.

Neurocrine Biosciences, Inc. (NBIX) full year performance was 58.20%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Neurocrine Biosciences, Inc. shares are logging -0.49% during the 52-week period from high price, and 80.70% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $72.14 and $131.00.

The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 2.62 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Neurocrine Biosciences, Inc. (NBIX) recorded performance in the market was 21.28%, having the revenues showcasing 47.23% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 11.93B, as it employees total of 700 workers.

Market experts do have their say about Neurocrine Biosciences, Inc. (NBIX)

According to the data provided on, the moving average of the company in the 100-day period was set at 103.57, with a change in the price was noted +27.26. In a similar fashion, Neurocrine Biosciences, Inc. posted a movement of +26.44% for the period of last 100 days, recording 861,003 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity. The total Debt to Equity ratio for NBIX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.59.

Technical breakdown of Neurocrine Biosciences, Inc. (NBIX)

Raw Stochastic average of Neurocrine Biosciences, Inc. in the period of last 50 days is set at 98.30%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 96.70%. In the last 20 days, the company’s Stochastic %K was 84.85% and its Stochastic %D was recorded 81.79%.

Bearing in mind the latest performance of Neurocrine Biosciences, Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 21.28%. Additionally, trading for the stock in the period of the last six months notably improved by 20.76%, alongside a boost of 58.20% for the period of the last 12 months. The shares increased approximately by 5.22% in the 7-day charts and went down by 1.19% in the period of the last 30 days. Common stock shares were driven by 47.23% during last recorded quarter.